FRANKFURT, Dec 14 (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly (LLY.N), opens new tab and Regeneron (REGN.O), opens new tab lose most of their effectiveness ...

Since late last year, federal officials have been asking, practically begging people to get booster doses of the COVID-19 vaccine. But more than half of Americans have ignored the request even for a ...

Blood collected from survivors of COVID-19 has been used to identify antibodies against the disease, which have been turned into experimental drugs to fight it. But it’s not an easy process. So back ...

WEST PALM BEACH, Fla. — If you've been infected with COVID-19 or got the vaccine, you likely have antibodies. But what does that really tell you? Waking up every day in a pandemic for Leigh Ann David ...

Last week, Adagio Therapeutics raised $80 million in a series B financing to speed its COVID-19 antibody into development. This week, it provided some details about how its approach differs from the ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how ...

ROCKVILLE, Md.--(BUSINESS WIRE)--20/20 GeneSystems, Inc., today announced that it has received its first allotment of the new Elecsys Anti-SARS-CoV-2 S lab-based blood test that quantitatively ...

Researchers developed a humanized mouse model that better predicts how antibody drugs interact with the immune system. The ...

German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant of coronavirus, ...